The company announced it would issue 7.75 million shares of its 10.00% Series A Perpetual Stream Preferred Stock (STRE) at €80 ($92.60) per share. Settlement is expected on Nov. 13, subject to ...
Strategy has revealed the costs and terms of its latest preferred stock offering amid a broad downturn in crypto treasury ...
Get key insights from OptimizeRx’s Q3 2025 earnings: strong growth, raised guidance, improved margins, and 2026 forecasts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback